Piper Sandler Maintains Overweight on CVRx, Raises Price Target to $33
Portfolio Pulse from Benzinga Newsdesk
Piper Sandler analyst Matt O'Brien has maintained an Overweight rating on CVRx and increased the price target from $21 to $33.
January 26, 2024 | 6:49 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Piper Sandler's analyst Matt O'Brien reaffirmed an Overweight rating on CVRx and raised the price target to $33, indicating a positive outlook on the stock.
The increase in price target by Piper Sandler suggests a strong conviction in CVRx's future performance. This is likely to be viewed positively by investors and could lead to a short-term increase in the stock price as market sentiment aligns with the analyst's upgraded outlook.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100